> 
Paris, January 31, 2007
Wisdom's strategy is based on a virtual screening of molecules with encouraging therapeutic performances: it allows researchers to calculate the probability that a molecule (called an active molecule or "ligand") will bind to a target protein, thereby altering its biological activity, and, in the case of malaria, the proliferation of the parasite. Over the ten weeks of the experiment, 4.3 million active molecules (potential medicines) were tested, and more than 140 million linkages between these molecules and the target proteins to combat malaria were calculated. Through this process, it was possible to reject a large number of compounds in record time, allowing researchers to focus the biological tests on the most promising chemical compounds. While accelerating the process of selection of the "best" molecules, this strategy can also substantially reduce the cost of developing new medicines against this disease which has an especially large impact on developing countries.
The impact of the approach used in Wisdom goes beyond malaria. This strategy can be extended to all diseases, opening up major possibilities for industry. Furthermore, Wisdom allows for a systematic investigation of all potentially valuable compounds whereas, until now, the search for new medicines in the academic sector was carried out on a small scale.
In 2005, the first large-scale deployment on the Egee grid screened more than 41 million chemical compounds in only six weeks, representing the equivalent of 80 years of calculations on a standard computer. Of the 5,000 best chemical compounds selected in this screening, three families of molecules in particular caught the attention of the researchers: two were already known for their action on the targeted protein while the third is completely new.
Analysis of the most promising compounds is continuing at the
AN INTERNATIONAL MOBILIZATION
The success of this first initiative attracted the interest of the international research community, which led to a deployment for avian influenza in April and May 2006 and then this second deployment for malaria for new target proteins proposed by French, Italian, Venezuelan and South African laboratories. Many calculation grids joined this effort: the regional grid Auvergrid in
For this second phase of the Wisdom project, more than 5,000 computers were mobilized simultaneously in 27 countries, producing more than 2,000 gigabits of data, which represents the equivalent of 413 years of calculations on a single computer. In
© Vinod Kasam - IN2P3/CNRS Simulation of the binding of a chemical compound with a mutated structure of the DHFR of Plasmodium falciparum which is the target of anti-malaria medicines. At left, an inhibitor of the non-mutated DHFR: the part in white shows the conformation of the ligand before the binding, the part in color shows its conformation when it is bound to the mutated DHFR.
1) World-wide In Silico Docking On Malaria is an international cooperation project involving IN2P3/CNRS, the Fraunhofer Institute (Germany), the University of Modena (Italy), the Institute of biomedical technologies (ITB-CNR, Italy), the "Sinica" Academy (Taiwan), the Healthgrid Association and Chonnam National University (South Korea). This initiative is supported by the German company BioSolveIT, which made more than 6,000 licenses for FlexX software available to the project partners.
2) The National Institute of Nuclear and Particle Physics.
3) The Wisdom experiment used a broad panel of calculation grids: the Egee and AuverGrid projects, the national grid of Taiwan ASGC TWGrid, the EELA, EUMedGRID and EUChinaGRID grids respectively deployed in South America, in the countries around the Mediterranean Sea and in China, which provide calculation resources, and also the BioinfoGRID and Embrace grids which improve the molecule selection process.
4) The Enabling Grids for E-sciencE (Egee) project is co-financed by the European Commission. It manages the largest multi-disciplinary grid infrastructure in the world, with close to 200 sites in a network.
5) The Calculation Center of the National Institute of Nuclear and Particle Physics (CC-IN2P3/CNRS) specializes in the providing of computer services needed for the analysis and interpretation of fundamental processes of sub-atomic physics. Some of its resources are allotted to research in other fields of science.
For further information about the applications:
Wisdom: View web site
Egee: View web site
AuverGrid: View web site
EELA: View web site
EUMedGrid: View web site
EUChinaGrid: View web site
TWGrid: View web site
BioinfoGrid: View web site
Embrace: View web site
Researcher
Vincent Breton
Telephone: 06 863257 51
breton@clermont.in2p3.fr
IN2P3/CNRS Communication
Christina Cantrel
Telephone: 01 449647 60
ccantrel@admin.in2p3.fr
Press
Priscilla Dacher
Telephone: 01 449646 06
priscilla.dacher@cnrs-dir.fr
Latest press releases
All disciplines